Our data, reporting the role of ABCA6 in diminishing intracellular cholesterol, decreasing caveolin-1 expression and inhibiting IGF1R signaling, are consistent with this evidence and support the hypothesis that the ability to form ordered domains is sufficient to support activation of IGF1R signaling and tumor growth. The gene discussed is ABCA6; the disease is neoplasm.